Address
343 Allerton Avenue, South San Francisco, CA, USA, 94080
VistaGen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of a major depressive disorder in patients with an inadequate response to standard antidepressants. The PH94B is a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia; PH10 is an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression.
| Saxe Jon S |
director |
FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076 |
| Dotson Jerrold Duane |
officer: VP, CFO AND SECRETARY |
5 CENTERPOINTE DRIVE SUITE 400 LAKE OSWEGO OR 97035 |
| Singh Shawn |
director, officer: CHIEF EXECUTIVE OFFICER |
C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 |
| Snodgrass H. Ralph |
director, officer: PRES./CHIEF SCIENTIFIC OFFICER |
384 OYSTER POINT BLVD. SUITE 8 SOUTH SAN FRANCISCO CA 94080 |
| Smith Mark Alan |
officer: CHIEF MEDICAL OFFICER |
343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 |
| Mcpartland Mark A. |
officer: VP CORPORATE DEVELOPMENT |
C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 |
| Gin Jerry B |
director |
343 ALLERTON AVE SOUTH SAN FRANCISCO CA 94080 |
| Underdown Brian J. |
director |
C/O LUMIRA CAPITAL INVESTMENT MANAGEMENT 141 ADELAIDE ST. WEST, SUITE 770 TORONTO ONTARIO CANADA M5H 3L5 A6 00000 |
| Cunningham Ann Michelle |
director |
255 N CALDWELL CIRCLE DOWNINGTOWN PA 19335 |
| Rice A. Franklin |
officer: VP CORPORATE DEVELOPMENT |
384 OYSTER POINT BLVD. SUITE 8 SOUTH SAN FRANCISCO CA 94080 |
| Bonfiglio Gregory A. |
director |
384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 |
| Platinum Long Term Growth Vii, Llc |
10 percent owner |
152 WEST 57TH STREET 4TH FLOOR NEW YORK NY 10019 |
| Cato Holding Co |
10 percent owner |
4364 SOUTH ALSTON AVENUE DURHAM NC 27713 |
| Cato Allen Easley |
10 percent owner |
4364 SOUTH ALSTON AVENUE DURHAM NC 27713 |
| Jones Stephanie |
director, 10 percent owner, officer: PRESIDENT |
13834 W. HOYT ROAD RATHDRUM ID 83858 |
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.04(3.92%) Volume: 1,926,517 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:VTGN has been successfully added to your 
